← SynDRA
NALOXEGOL
SynDRA canonical compound SYN0034461 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | OPRM1 |
|---|
| Mechanism of action | opioid receptor antagonist |
|---|
| Indication | constipation |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- OPRM1 ANTAGONIST
- Mu opioid receptor antagonist
- opioid receptor antagonist
- OPRM1 MODULATOR
Drug classes
- Central Nervous System Agents
- Narcotic Antagonists
- Peripheral Nervous System Agents
- Sensory System Agents
- Opioid Antagonists
- Opioid Antagonist
ATC classes
- A06A · DRUGS FOR CONSTIPATION
Cross-references
Synonyms
- moventig
- naloxegol oxalate
- movantik
- NKTR-118
- AZ-13337019
- Moventig
- NKTR 118
- naloxegol (nflis-drug)
- NKTR118
- AZ13337019
- CHEBI:82975
- naloxegolum
- RefChem:57232
- A06AH03
- DTXCID10157175
- Movantik
- Naloxegol [INN]
- Naloxegol [USAN:INN]
- UNII-44T7335BKE
- Naloxone Impurity 20
- NALOXEGOL [MI]
- Naloxegol (USAN/INN)
- NALOXEGOL [USAN]
- Naloxegol (NKTR-118)
- NALOXEGOL [WHO-DD]
- NALOXEGOL [NFLIS-DRUG]
- GTPL7539
- orb1693794
- SCHEMBL19433066
- HSDB 8338
- XNKCCCKFOQNXKV-ZRSCBOBOSA-N
- GLXC-23930
- HY-A0118
- ARD193816
- EBC-27414
- NSC787509
- AKOS030526932
- CS-4987
Reported adverse events
- Flatulence
- Gastrointestinal perforation
- Headache
- Hyperhidrosis
- Hypersensitivity
- Gastrointestinal disorder
- Nausea
- Vomiting
Look up NALOXEGOL in the interactive SynDRA portal →